Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-6-8
pubmed:abstractText
Fluticasone furoate (USAN-approved name) is a novel, enhanced-affinity glucocorticoid administered in a unique side-actuated device for the management of seasonal allergic rhinitis (SAR).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0091-6749
pubmed:author
pubmed:issnType
Print
pubmed:volume
119
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1430-7
pubmed:dateRevised
2010-5-12
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis.
pubmed:affiliation
Clinical Research Institute, Minneapolis, MN 55402, USA. hbk@allergy-asthma-docs.com
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III